ZC3H15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.70130617663744E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.37630004562561E-09 |
Normal-vs-Stage2 |
2.001700E-03 |
Normal-vs-Stage3 |
2.78299605582788E-11 |
Normal-vs-Stage4 |
5.07469999355692E-09 |
Stage1-vs-Stage2 |
9.079000E-01 |
Stage1-vs-Stage3 |
1.556060E-02 |
Stage1-vs-Stage4 |
4.380300E-02 |
Stage2-vs-Stage3 |
1.166810E-01 |
Stage2-vs-Stage4 |
1.668780E-01 |
Stage3-vs-Stage4 |
9.204800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.56308299636976E-12 |
Normal-vs-AfricanAmerican |
6.45880000038623E-07 |
Normal-vs-Asian |
3.016000E-02 |
Caucasian-vs-AfricanAmerican |
4.223200E-01 |
Caucasian-vs-Asian |
6.895200E-01 |
AfricanAmerican-vs-Asian |
4.796000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.7715611723761E-15 |
Normal-vs-Female |
2.56659999997577E-06 |
Male-vs-Female |
4.057400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.69140000005896E-07 |
Normal-vs-Age(41-60Yrs) |
3.2971003705029E-10 |
Normal-vs-Age(61-80Yrs) |
2.441302715539E-11 |
Normal-vs-Age(81-100Yrs) |
1.111600E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.096600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.690400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.250800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.280200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.622200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.657000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.101800E-02 |
Normal-vs-Grade 2 |
1.25330000044777E-07 |
Normal-vs-Grade 3 |
2.44515518943444E-12 |
Normal-vs-Grade 4 |
2.10730000116399E-09 |
Grade 1-vs-Grade 2 |
7.797000E-01 |
Grade 1-vs-Grade 3 |
2.689200E-01 |
Grade 1-vs-Grade 4 |
1.475040E-01 |
Grade 2-vs-Grade 3 |
3.162500E-02 |
Grade 2-vs-Grade 4 |
1.018170E-02 |
Grade 3-vs-Grade 4 |
2.428800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.198900E-04 |
Normal-vs-ccB subtype |
1.62803104331033E-12 |
ccA subtype-vs-ccB subtype |
3.94500000000519E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.21709975431372E-10 |
Normal-vs-N1 |
7.404000E-03 |
N0-vs-N1 |
4.832200E-01 |
|
|